J Fangmann
Overview
Explore the profile of J Fangmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fangmann J, Braune C, Scheumann G
Saudi Med J
. 2016 Sep;
20(12):984.
PMID: 27644728
Full text is available as a scanned copy of the original print version.
2.
Fangmann J, Kathrin Al-Ali H, Sack U, Kamprad M, Tautenhahn H, Faber S, et al.
Am J Transplant
. 2011 Jan;
11(1):156-62.
PMID: 21199355
In January 2005, an 18-year-old male patient with acute myeloid leukemia (AML) received a haploidentical hematopoietic stem cell transplantation (HSCT) from his father. He developed hemolytic uremic syndrome and end-stage...
3.
Successful liver transplantation in antituberculosis therapy-induced acute fulminant hepatic failure
Schneider R, Bercker S, Schubert S, Tillmann H, Fangmann J, Hauss J, et al.
Transplant Proc
. 2009 Nov;
41(9):3934-6.
PMID: 19917416
The antituberculosis drugs isoniazid, rifampin, and pyrazinamide expose patients to the risk of hepatotoxicity ranging from an asymptomatic increase in aminotransferase concentrations to fulminant hepatic failure. Herein, we report a...
4.
Rayya F, Harms J, Bartels M, Uhlmann D, Hauss J, Fangmann J
Transplant Proc
. 2008 Jun;
40(4):933-5.
PMID: 18555082
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Both liver resection (LR) and orthotopic liver transplantation (OLT) are surgical treatment options depending on the size of the...
5.
Rayya F, Harms J, Martin A, Bartels M, Hauss J, Fangmann J
Transplant Proc
. 2008 Jun;
40(4):891-4.
PMID: 18555073
Background: A safe and effective preservation solution is a precondition for successful orthotopic liver transplantation (OLT). This study compared University of Wisconsin (UW) and histidine-tryptophan-ketoglutarate (HTK) solutions in OLT. Patients...
6.
Martin A, Bartels M, Hauss J, Fangmann J
Transplant Proc
. 2007 Dec;
39(10):3169-74.
PMID: 18089345
On February 27, 2002, the United Network for Organ Sharing (UNOS) introduced a new allocation policy for cadaveric liver transplants, based on the Model for End-Stage Liver Disease (MELD) score....
7.
Fangmann J, Wegmann C, Hoppe A, MARTIN P, Sack U, Harms J, et al.
Transplant Proc
. 2007 Dec;
39(10):3101-4.
PMID: 18089331
Dendritic cells (DCs) play a key role in transplantation tolerance and immune reactions to transplants. In order to ascertain whether DC levels are predictive for rejection, we examined the levels...
8.
Martin A, Bartels M, Schreiber S, Buehrdel P, Hauss J, Fangmann J
Transplant Proc
. 2006 Dec;
38(10):3615-9.
PMID: 17175348
Glycogen storage disease type Ib is a rare metabolic disease caused by a defect of the G6P transporter. Patients suffer from hypoglycemic episodes; growth and developmental delay; osteoporosis; neutropenia; and...
9.
Overbeck I, Bartels M, Decker O, Harms J, Hauss J, Fangmann J
Transplant Proc
. 2005 May;
37(3):1618-21.
PMID: 15866689
Quality of life is becoming an increasingly important concept in the evaluation of different therapeutic interventions. In this cross-sectional study, quality of life analyzed in 76 renal transplant patients was...
10.
Harms J, Bartels M, Bourquain H, Peitgen H, Schulz T, Kahn T, et al.
Transplant Proc
. 2005 Apr;
37(2):1059-62.
PMID: 15848622
Introduction: For living donor liver transplantation (LDLT) accurate diagnostic workup is essential. Multiple imaging approaches are currently used. Problems arise in the assessment of vascular and bile duct anatomy, liver...